Jumadil, Karina .
HRN: 24-79-23 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/07/2024
CEFUROXIME 1.5GM (VIAL)
04/07/2024
04/12/2024
IV
1.5 Gms
Q8
2 Degree LACERARTION; NID,
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes